Discovery of small-molecule fluorescent probes for C-Met

Area of Science:

• Biochemistry
• Molecular Biology
• Chemical Biology

Background:

• C-mesenchymal-epithelia transition factor (c-Met) is a key driver in the growth and development of various solid tumors, including gastric, liver, and lung cancers.
• Targeting c-Met is a significant strategy for developing novel anti-cancer therapies and understanding tumor progression.

Purpose of the Study:

• To design and synthesize novel small-molecule fluorescent probes capable of targeting and imaging c-Met.
• To evaluate the inhibitory activity and binding affinity of the developed probes against c-Met.
• To confirm the probes' utility in visualizing c-Met expression in living cancer cells.

Main Methods:

• Synthesis and characterization of three small-molecule fluorescent probes (compounds 5, 11, and 16).
• Assessment of fluorescence properties and inhibitory activities against c-Met.
• Fluorescence polarization assays and flow cytometry to verify probe-c-Met binding.
• Live-cell imaging studies to evaluate c-Met labeling in cancer cells.

Main Results:

• The developed fluorescent probes exhibited suitable fluorescence properties for bioimaging applications.
• Probes demonstrated significant inhibitory activities against c-Met, with probe 16 showing particularly strong performance.
• Binding assays confirmed the specific interaction between the probes and c-Met.
• Cell imaging experiments successfully visualized c-Met in living cells, validating the probes' targeting capability.

Conclusions:

• The developed fluorescent probes are effective tools for targeting and imaging c-Met in living cells.
• Probe 16 shows promise as a lead compound for developing c-Met kinase inhibitors.
• These probes hold potential for advancing tumor pathology research and the development of targeted cancer therapies.